Gregory L. Verdine - Net Worth and Insider Trading
Gregory L. Verdine Net Worth
The estimated net worth of Gregory L. Verdine is at least $210,531 dollars as of 2024-09-20. Gregory L. Verdine is the Director of WAVE Life Sciences Ltd and owns about 30,000 shares of WAVE Life Sciences Ltd (WVE) stock worth over $174,000. Gregory L. Verdine is also the Director of Enanta Pharmaceuticals Inc and owns about 3,324 shares of Enanta Pharmaceuticals Inc (ENTA) stock worth over $36,531. Details can be seen in Gregory L. Verdine's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Gregory L. Verdine has not made any transactions after 2019-11-20 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Gregory L. Verdine
Gregory L. Verdine Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Gregory L. Verdine owns 2 companies in total, including WAVE Life Sciences Ltd (WVE) , and Enanta Pharmaceuticals Inc (ENTA) .
Click here to see the complete history of Gregory L. Verdine’s form 4 insider trades.
Insider Ownership Summary of Gregory L. Verdine
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| WVE | WAVE Life Sciences Ltd | 2019-11-20 | director |
| ENTA | Enanta Pharmaceuticals Inc | 2013-03-26 | director |
Gregory L. Verdine Latest Holdings Summary
Gregory L. Verdine currently owns a total of 2 stocks. Among these stocks, Gregory L. Verdine owns 30,000 shares of WAVE Life Sciences Ltd (WVE) as of November 20, 2019, with a value of $174,000 and a weighting of 82.65%. Gregory L. Verdine also owns 3,324 shares of Enanta Pharmaceuticals Inc (ENTA) as of March 26, 2013, with a value of $36,531 and a weighting of 17.35%.
Latest Holdings of Gregory L. Verdine
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| WVE | WAVE Life Sciences Ltd | 2019-11-20 | 30,000 | 5.80 | 174,000 |
| ENTA | Enanta Pharmaceuticals Inc | 2013-03-26 | 3,324 | 10.99 | 36,531 |
Holding Weightings of Gregory L. Verdine
Gregory L. Verdine Form 4 Trading Tracker
According to the SEC Form 4 filings, Gregory L. Verdine has made a total of 1 transactions in WAVE Life Sciences Ltd (WVE) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in WAVE Life Sciences Ltd is the sale of 30,039 shares on November 20, 2019, which brought Gregory L. Verdine around $920,095.
According to the SEC Form 4 filings, Gregory L. Verdine has made a total of 0 transactions in Enanta Pharmaceuticals Inc (ENTA) over the past 5 years. The most-recent trade in Enanta Pharmaceuticals Inc is the acquisition of 3,324 shares on March 26, 2013, which cost Gregory L. Verdine around $46,536.
Insider Trading History of Gregory L. Verdine
- 1
Gregory L. Verdine Trading Performance
GuruFocus tracks the stock performance after each of Gregory L. Verdine's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Gregory L. Verdine is 6.5%. GuruFocus also compares Gregory L. Verdine's trading performance to market benchmark return within the same time period. The performance of stocks bought by Gregory L. Verdine within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Gregory L. Verdine's insider trading performs compared to the benchmark.
Performance of Gregory L. Verdine
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 20.66 | | | | | |
| Relative Return to S&P 500(%) | 19.48 | | | | | |
Gregory L. Verdine Ownership Network
Gregory L. Verdine Owned Company Details
What does WAVE Life Sciences Ltd do?
Who are the key executives at WAVE Life Sciences Ltd?
Gregory L. Verdine is the director of WAVE Life Sciences Ltd. Other key executives at WAVE Life Sciences Ltd include director & See Remarks Paul Bolno , See Remarks Kyle Moran , and 10 percent owner Ra Capital Healthcare Fund Lp .
WAVE Life Sciences Ltd (WVE) Insider Trades Summary
Over the past 18 months, Gregory L. Verdine made no insider transaction in WAVE Life Sciences Ltd (WVE). Other recent insider transactions involving WAVE Life Sciences Ltd (WVE) include a net purchase of 2,000,000 shares made by Ra Capital Healthcare Fund Lp , a net sale of 52,692 shares made by Kyle Moran , and a net purchase of 3,300,000 shares made by Plc Glaxosmithkline .
In summary, during the past 3 months, insiders sold 48,366 shares of WAVE Life Sciences Ltd (WVE) in total and bought 0 shares, with a net sale of 48,366 shares. During the past 18 months, 101,058 shares of WAVE Life Sciences Ltd (WVE) were sold and 5,300,000 shares were bought by its insiders, resulting in a net purchase of 5,198,942 shares.
WAVE Life Sciences Ltd (WVE)'s detailed insider trading history can be found in Insider Trading Tracker table.
WAVE Life Sciences Ltd Insider Transactions
Gregory L. Verdine Mailing Address
Above is the net worth, insider trading, and ownership report for Gregory L. Verdine. You might contact Gregory L. Verdine via mailing address: C/o Wave Life Sciences Ltd., 733 Concord Ave, Cambridge Ma 02138.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
